A novel series of AKT inhibitors containing 2, 3, 5-trisubstituted pyridines with novel azaindazoles as hinge binding elements are described. Among these, the 4, 7- diazaindazole compound 2c has improved drug-like properties and kinase selectivity than those of indazole 1, and displays greater than 80% inhibition of GSK3β phosphorylation in a BT474 tumor xenograft model in mice.